MARKET

HQH

HQH

abrdn Healthcare Investors
NYSE
14.86
+0.26
+1.81%
Opening 09:59 11/29 EST
OPEN
14.70
PREV CLOSE
14.60
HIGH
14.86
LOW
14.62
VOLUME
37.33K
TURNOVER
0
52 WEEK HIGH
19.61
52 WEEK LOW
14.31
TOTAL ASSET
878.58M
YTD YIELD
-8.38%
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at HQH last week (1120-1124)?
Weekly Report · 2d ago
DPG: Top 25 Big-Yield CEFs
Duff & phelps utility and infrastructure fund has a 9.2% yield. The fund has been slammed for its utilities sector exposure and recent distribution rightsizing. Duff & phelps is one of the top 25 big-yield cefs in the blue harbinger index.
Seeking Alpha · 5d ago
Weekly Report: what happened at HQH last week (1113-1117)?
Weekly Report · 11/20 09:01
HQH: Discount To NAV Offers Attractive Entry Opportunity
Abrdn healthcare investors is a closed-ended fund focused on the global biotech & healthcare sector with a 10% dividend yield. Tekla capital management's funds were acquired by abrdn on october 27th. Hqh is currently trading at a 17.28% discount to nav, indicating a potential 10% upside to historical averages.
Seeking Alpha · 11/15 22:43
HQH: New Name But Same Risky Bets On Biotech
Abrdn healthcare investors fund's heavy exposure to biotechnology has led to sub-par returns due to higher interest rates and poor equity risk appetites. Abrdn has renamed the fund but day-to-day management remains the same. I continue to recommend caution with the hqh fund.
Seeking Alpha · 11/14 13:00
Weekly Report: what happened at HQH last week (1106-1110)?
Weekly Report · 11/13 09:01
abrdn Healthcare Investors declares $0.38 dividend
Abrdn healthcare investors declares $0.38/share monthly dividend, in line with previous. Payable jan. 10; for shareholders of record nov. 22; ex-div nov. 21. Abrdn healthcare investors (hqh) is a biopharma company.
Seeking Alpha · 11/10 16:48
abrdn Healthcare Investors Closed End Fund: Initial statement of beneficial ownership of securities
Press release · 11/06 21:07
More
Profile
Fund Name
abrdn Healthcare Investors
Inception Date
1987-04-23
Benchmark
NASDAQ Biotechnology TR USD
Advisor Company
Tekla Capital Management LLC
Custodian
State Street Bank and Trust Co
Manager
Daniel Omstead